Congress Asset Management »

Ultragenyx Pharmaceutical shares owned by Congress Asset Management

Quarter-by-quarter ownership of Ultragenyx Pharmaceutical (RARE) shares owned by Congress Asset Management from 13F filings

Historical chart of Congress Asset Management investment in Ultragenyx Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including Ultragenyx Pharmaceutical held by Congress Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ultragenyx Pharmaceutical by Congress Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $941k 45k 20.95

More positions owned by Congress Asset Management

NVIDIA Corporation (NVDA)
Apple (AAPL)
Alphabet Inc Class A cs (GOOGL)
Microsoft Corporation (MSFT)
Broadcom (AVGO)
Costco Wholesale Corporation (COST)
Arista Networks (ANET)
Sterling Construction Company (STRL)
TJX Companies (TJX)
Amazon (AMZN)
Howmet Aerospace (HWM)
Eaton (ETN)
Facebook Inc cl a (META)
Ge Vernova (GEV)
Visa (V)

View all positions for Congress Asset Management

Top funds holding Ultragenyx Pharmaceutical

Vanguard Group
BlackRock
State Street Corporation
Sands Capital Management
Rtw Investments
Baker Bros. Advisors
FMR
Citadel Advisors
Wellington Management Company
Suvretta Capital Management
Frontier Capital Management
Bnp Paribas Investment Partners
Geode Capital Management
Jacobs Levy Equity Management
Standard Life Aberdeen

View all funds holding Ultragenyx Pharmaceutical